Immuneering (IMRX) Institutional Ownership $3.04 -0.18 (-5.59%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$3.08 +0.04 (+1.15%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Immuneering (NASDAQ:IMRX)CurrentInstitutional OwnershipPercentage67.65%Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$1.27MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$1.51M Get IMRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immuneering stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMRX Institutional Buying and Selling by Quarter Immuneering Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 Marshall Wace LLP573,864$1.93M0.0%-29.0%1.595% 8/12/2025 XTX Topco Ltd26,829$90K0.0%N/A0.075% 8/8/2025 Kingsview Wealth Management LLC14,000$47K0.0%N/A0.039% 8/8/2025 Geode Capital Management LLC230,275$776K0.0%+2.0%0.640% 7/16/2025 Flower City Capital32,029$108K0.1%N/A0.089% 5/19/2025Jane Street Group LLC20,869$32K0.0%N/A0.058% 5/13/2025 HighTower Advisors LLC83,960$128K0.0%+17.7%0.233% 5/7/2025 TD Asset Management Inc71,066$108K0.0%-52.9%0.197% 2/17/2025Two Sigma Investments LP50,557$111K0.0%+25.0%0.163% 2/17/2025Tang Capital Management LLC12,073$27K0.0%N/A0.039% Get the Latest News and Ratings for IMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immuneering and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Southport Management L.L.C.215,000$473K1.7%+4.9%0.692% 2/17/2025Millennium Management LLC102,936$226K0.0%-58.2%0.332% 2/17/2025First Manhattan CO. LLC.32,325$71K0.0%N/A0.104% 2/17/2025Bridgeway Capital Management LLC51,349$113K0.0%+77.4%0.165% 2/14/2025Price T Rowe Associates Inc. MD767,124$1.69M0.0%-5.3%2.471% 2/13/2025 Marshall Wace LLP21,432$47K0.0%N/A0.069% 2/13/2025 XTX Topco Ltd32,650$72K0.0%+177.2%0.105% 2/13/2025 Rockefeller Capital Management L.P.177,377$390K0.0%N/A0.571% 2/10/2025 Tidemark LLC44,400$98K0.0%-14.4%0.143% 2/7/2025 HighTower Advisors LLC71,360$157K0.0%+33.7%0.230% 11/16/2024 Geode Capital Management LLC209,641$522K0.0%-5.5%0.707% 11/15/2024 XTX Topco Ltd11,779$29K0.0%-65.5%0.040% 11/15/2024 HighTower Advisors LLC53,360$132K0.0%+21.4%0.180% 11/15/2024Point72 Asia Singapore Pte. Ltd.17,824$44K0.0%-48.5%0.060% 11/14/2024 Corsair Capital Management L.P.10,000$25K0.0%N/A0.034% 11/7/2024 Tidemark LLC51,850$129K0.1%N/A0.175% 10/16/2024 Vontobel Holding Ltd.10,000$25K0.0%N/A0.034% 10/10/2024 Exchange Traded Concepts LLC58,349$145K0.0%-22.1%0.197% 9/16/2024Point72 Asia Singapore Pte. Ltd.34,609$44K0.0%N/A0.117% 8/15/2024Point72 Asia Singapore Pte. Ltd.34,609$44K0.0%N/A0.117% 8/14/2024 Marshall Wace LLP384,075$492K0.0%N/A1.295% 8/12/2024 XTX Topco Ltd34,159$44K0.0%+37.3%0.115% 8/9/2024 Renaissance Technologies LLC349,100$447K0.0%N/A1.177% 8/6/2024 Acadian Asset Management LLC53,445$67K0.0%N/A0.180% 5/15/2024Price T Rowe Associates Inc. MD910,266$2.63M0.0%-73.1%3.070% 5/10/2024 Vanguard Group Inc.1,203,666$3.48M0.0%+12.1%4.060% 2/12/2024 TD Asset Management Inc197,876$1.45M0.0%-30.4%0.676% 1/5/2024 Exchange Traded Concepts LLC17,416$128K0.0%+34.0%0.060% 11/15/2023Adage Capital Partners GP L.L.C.195,000$1.50M0.0%+11.4%0.666% 11/14/2023 Corton Capital Inc.18,847$145K0.1%N/A0.064% HIDDEN IN THE BOOK OF GENESIS… (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code11/13/2023Southport Management L.L.C.17,500$134K0.7%N/A0.060% 11/13/2023FMR LLC612,168$4.70M0.0%-7.0%2.092% 11/13/2023 PNC Financial Services Group Inc.20,000$154K0.0%N/A0.068% 10/27/2023 TD Asset Management Inc284,476$2.19M0.0%+100.0%0.972% 10/18/2023 Exchange Traded Concepts LLC12,999$100K0.0%-12.7%0.044% 9/8/2023Tucker Asset Management LLC11,036$112K0.0%N/A0.038% 8/15/2023HighVista Strategies LLC253,110$2.57M1.2%N/A0.865% 8/14/2023Cormorant Asset Management LP4,204,364$42.63M2.4%+76.2%14.369% 8/11/2023 ExodusPoint Capital Management LP127,719$1.30M0.0%+48.0%0.436% 8/9/2023 TD Asset Management Inc142,238$1.44M0.0%-1.3%0.486% 8/4/2023 American International Group Inc.9,761$99K0.0%N/A0.033% 8/2/2023 Bank of Montreal Can714,037$8.00M0.0%N/A2.441% 7/26/2023 Janney Montgomery Scott LLC22,135$224K0.0%N/A0.076% 7/20/2023 Exchange Traded Concepts LLC14,884$151K0.0%N/A0.051% 5/11/2023 ExodusPoint Capital Management LP86,297$838K0.0%N/A0.295% 5/9/2023 Y Intercept Hong Kong Ltd11,114$108K0.0%N/A0.038% 11/15/2022Citadel Advisors LLC2,184,909$31.29M0.0%-0.7%8.273% 8/4/2022 TD Asset Management Inc.147,661$799K0.0%+21.8%0.560% 5/10/2022 TD Asset Management Inc.121,201$784K0.0%+253.4%0.459% 2/15/2022Adage Capital Partners GP L.L.C.314,000$5.08M0.0%N/A1.210% 2/14/2022Citadel Advisors LLC2,058,102$32.04M0.0%+0.1%7.934% 2/8/2022 Northern Trust Corp75,891$1.23M0.0%+4.5%0.293% 2/2/2022 New York State Common Retirement Fund4,637$75K0.0%+172.8%0.018% 1/28/2022 Allspring Global Investments Holdings LLC9,228$149K0.0%N/A0.036% 12/3/2021Perceptive Advisors LLC681,051$18.08M0.3%N/A2.625% 11/16/2021Suvretta Capital Management LLC200,000$5.31M0.1%N/A0.771% 11/16/2021 Metropolitan Life Insurance Co NY2,814$75K0.0%N/A0.011% 11/16/2021Millennium Management LLC89,788$2.38M0.0%N/A0.346% 11/16/2021Citadel Advisors LLC2,055,459$52.40M0.0%N/A7.924% 11/15/2021Rock Springs Capital Management LP1,089,816$28.94M0.6%N/A4.201% 11/15/2021 Marshall Wace LLP13,149$349K0.0%N/A0.051% 11/15/2021Caas Capital Management LP40,000$1.06M0.0%N/A0.154% 11/12/2021Ghisallo Capital Management LLC15,000$398K0.0%N/A0.058% 11/12/2021 Geode Capital Management LLC122,319$3.25M0.0%N/A0.472% 11/10/2021 Citigroup Inc.1,246$33K0.0%N/A0.005% 11/9/2021BlackRock Inc.1,524,374$40.47M0.0%N/A5.877% 11/9/2021 TD Asset Management Inc.34,296$911K0.0%N/A0.132% 11/4/2021 Deutsche Bank AG4,752$126K0.0%N/A0.018% 11/2/2021 New York State Common Retirement Fund1,700$45K0.0%N/A0.007% (Data available from 1/1/2016 forward) IMRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMRX shares? During the previous two years, 30 institutional investors and hedge funds held shares of Immuneering. The most heavily invested institutionals were FMR LLC ($4.70M), Vanguard Group Inc. ($3.48M), HighVista Strategies LLC ($2.57M), Marshall Wace LLP ($1.93M), Price T Rowe Associates Inc. MD ($1.69M), Adage Capital Partners GP L.L.C. ($1.50M), and Geode Capital Management LLC ($776K).Learn more on Immuneering's institutional investors. What percentage of Immuneering's stock is owned by institutional investors? 67.65% of Immuneering's stock is owned by institutional investors. Learn more on IMRX's institutional investor holdings. Which institutional investors have been buying Immuneering's stock? Of the 27 institutional investors that purchased Immuneering's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Marshall Wace LLP ($405.51K), Renaissance Technologies LLC ($349.10K), HighVista Strategies LLC ($253.11K), Rockefeller Capital Management L.P. ($177.38K), TD Asset Management Inc ($142.24K), Vanguard Group Inc. ($129.85K), and Point72 Asia Singapore Pte. Ltd. ($69.22K). How much institutional buying is happening at Immuneering? Institutional investors have bought a total of 551,248 shares in the last 24 months. This purchase volume represents approximately $1.27M in transactions. Which of Immuneering's major shareholders have been selling company stock? Of the 9 institutional investors that sold Immuneering's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Marshall Wace LLP ($234.11K), Millennium Management LLC ($143.33K), TD Asset Management Inc ($79.81K), Price T Rowe Associates Inc. MD ($43.00K), XTX Topco Ltd ($22.38K), Point72 Asia Singapore Pte. Ltd. ($16.79K), and Exchange Traded Concepts LLC ($16.59K). How much institutional selling is happening at Immuneering? Institutional investors have sold a total of 575,617 shares in the last 24 months. This volume of shares sold represents approximately $1.51M in transactions. Related Companies TERN Major Shareholders SIGA Major Shareholders PRTC Major Shareholders GOSS Major Shareholders CGEM Major Shareholders SVRA Major Shareholders SNDL Major Shareholders MBX Major Shareholders ATYR Major Shareholders CMPS Major Shareholders This page (NASDAQ:IMRX) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuneering Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Immuneering With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.